Experiences with interferon-free hepatitis C therapies: addressing barriers to adherence and optimizing treatment outcomes

BACKGROUND: Millions of Americans are living with hepatitis C, the leading cause of liver disease in the United States. Medication treatment can cure hepatitis C. We sought to understand factors that contribute to hepatitis C treatment completion from the perspectives of patients and providers. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Skolnik, Avy A., Noska, Amanda, Yakovchenko, Vera, Tsai, Jack, Jones, Natalie, Gifford, Allen L., McInnes, D. Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359844/
https://www.ncbi.nlm.nih.gov/pubmed/30709352
http://dx.doi.org/10.1186/s12913-019-3904-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359844/
https://www.ncbi.nlm.nih.gov/pubmed/30709352
http://dx.doi.org/10.1186/s12913-019-3904-9

Ejemplares similares